In a new study published in Cancer Immunology Research, scientists at the Icahn School of Medicine at Mount Sinai have ...

Vor Biopharma Inc. (NASDAQ:VOR) is one of the hot penny stocks to invest in now. In a report released on June 30, ...

A new federal initiative seeks to develop stem cell treatments and other technology to repair brain tissue damaged by stroke, ...

Seoul, Seoul / Syndication Cloud / July 13, 2025 / Lydian Cosmetic Surgery Clinic Key Takeaways: Orthopedic non-invasive stem cell therapy regenerates damaged tissue rather than just improving ...

Matt Bellina Regained Function After Receiving NurOwn via the Right to Try Law He Fought to Pass and Now He is Fighting for All Americans with ALS to Get the Same Chance He Did BREMERTON, WA / ACCESS ...

MiNK Therapeutics, Inc. (NASDAQ:INKT) saw its stock soar by 200% following the announcement of a remarkable cancer remission ...

Genmab A/S (NASDAQ:GMAB) is one of the 10 Best Growth Stocks to Buy With Huge Upside Potential. On June 15, Genmab A/S (NASDAQ:GMAB) announced results from its EPCORE NHL-2 trial, Arm 10.

Pizza Palooza, the ultimate event for the pizza connoisseur, is back at Blossom Heath Park in St. Clair Shores for the second ...

Stem cell therapy is redefining recovery. See how it works, who it helps, and why more Texans should consider it as a ...

Tom Lee, head of research at Fundstrat, joined CNBC to discuss how the US tariffs might impact the market, economy, and inflation.

A study led by Cambridge researchers has shed light on how neural stem cell grafts could help restore myelin in the central nervous system.